SHELTON, Conn., May 30, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced that it will present at the Deutsche Bank dbAccess Global Consumer Conference in Paris on Tuesday June 4, 2023, at 3:45 P.M. CEST (9:45 A.M. ET) Rod Little, President and Chief Executive Officer and Dan Sullivan, CFO and President, Europe and Latin America will be presenting for Edgewell. All interested parties may access a live webcast of these events at www.edgewell.com, under "Investors," and "News and ...

Group 1 - The Zacks Rank emphasizes earnings estimates and revisions to identify strong stocks, while also considering value, growth, and momentum trends [1] - Value investing is a popular strategy that relies on traditional analysis of key valuation metrics to find undervalued stocks [2] - The Style Scores system can help investors find stocks with specific traits, particularly in the "Value" category [3] Group 2 - Edgewell Personal Care (EPC) has a Zacks Rank of 1 (Strong Buy) and a Value grade of A, indicating strong potential for value investors [4] - EPC's P/E ratio is 12.60, significantly lower than the industry average of 18.05, suggesting it may be undervalued [4] - The stock's P/CF ratio is 9.12, which is attractive compared to the industry's average P/CF of 18.47, further indicating undervaluation [5] Group 3 - The metrics suggest that Edgewell Personal Care is likely undervalued, and its strong earnings outlook makes it an appealing value stock [6]

The Eighth Annual Awards Honors The Brand's 'Nest Domes' Project, Amongst New and Inspiring Solutions to the Most Daunting Challenges of Today SHELTON, Conn., May 14, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) and its sun care brand, Banana Boat, have been named as a Nature Finalist for Fast Company's 2024 World Changing Ideas Award for its 'Nest Domes' project, aimed at supporting sea turtle conservation. The award highlights creative projects across a variety of topics that are helpin ...

Edgewell Personal Care (EPC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a c ...

SHELTON, Conn., May 9, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced that Rod Little, President and CEO and Dan Sullivan, CFO, President-Europe and LATAM will participate in a fireside chat at the Goldman Sachs Global Staples Forum in New York, NY on Tuesday May 14, 2024, at 11:00 A.M. ET.  All interested parties may access a live webcast of these events at www.edgewell.com, under "Investors," and "News and Events" tabs or by using the following link:   http://ir.edgewell.c ...

[Part I. Financial Information](index=3&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This section provides the company's financial statements, management's discussion and analysis, market risk disclosures, and controls and procedures [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) This section presents Edgewell Personal Care Company's unaudited condensed consolidated financial statements and detailed explanatory notes [Condensed Consolidated Statements of Earnings and Comprehensive Income](index=3&type=section&id=Condensed%20Consolidated%20Statements%20of%20Earnings%20and%20Comprehensive%20Income) Net sales for the three months ended March 31, 2024, were $599.4 million, with net earnings increasing to $36.0 million Consolidated Earnings Highlights (in millions, except per share data) | Metric | Three Months Ended Mar 31, 2024 | Three Months Ended Mar 31, 2023 | Six Months Ended Mar 31, 2024 | Six Months Ended Mar 31, 2023 | | :--- | :--- | :--- | :--- | :--- | | Net sales | $599.4 | $598.4 | $1,088.3 | $1,067.5 | | Gross profit | $258.1 | $242.3 | $455.8 | $431.9 | | Operating income | $70.1 | $56.8 | $96.2 | $88.7 | | Net earnings | $36.0 | $19.4 | $40.8 | $31.8 | | Diluted net earnings per share | $0.72 | $0.37 | $0.81 | $0.61 | [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2024, total assets were $3,756.3 million, with total shareholders' equity increasing to $1,551.3 million Balance Sheet Summary (in millions) | Metric | March 31, 2024 | September 30, 2023 | | :--- | :--- | :--- | | Total current assets | $994.8 | $962.4 | | Total assets | $3,756.3 | $3,740.7 | | Total current liabilities | $541.9 | $523.4 | | Long-term debt | $1,350.8 | $1,360.7 | | Total liabilities | $2,205.0 | $2,200.2 | | Total shareholders' equity | $1,551.3 | $1,540.5 | [Condensed Consolidated Statements of Cash Flows](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities for the six months ended March 31, 2024, significantly improved to $56.1 million Cash Flow Summary for Six Months Ended March 31 (in millions) | Activity | 2024 | 2023 | | :--- | :--- | :--- | | Net cash provided by operating activities | $56.1 | $1.9 | | Net cash used by investing activities | $(19.7) | $(20.0) | | Net cash used by financing activities | $(59.4) | $(29.0) | | Net decrease in cash and cash equivalents | $(20.2) | $(33.5) | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes provide detailed information on business segments, restructuring charges, debt, and segment performance data - The company operates in three segments: **Wet Shave**, **Sun and Skin Care**, and **Feminine Care**[26](index=26&type=chunk) - For the six months ended March 31, 2024, the company incurred **$10.0 million** in restructuring charges for its operating model redesign[33](index=33&type=chunk)[34](index=34&type=chunk) - As of March 31, 2024, total long-term debt was **$1,350.8 million**, primarily from senior notes due in 2028 and 2029[46](index=46&type=chunk) - During the six months ended March 31, 2024, the company repurchased **0.8 million shares** for **$30.3 million**, with **3.8 million shares** remaining for repurchase[54](index=54&type=chunk) Segment Net Sales for Six Months Ended March 31 (in millions) | Segment | 2024 | 2023 | | :--- | :--- | :--- | | Wet Shave | $594.8 | $583.9 | | Sun and Skin Care | $351.2 | $322.6 | | Feminine Care | $142.3 | $161.0 | | **Total net sales** | **$1,088.3** | **$1,067.5** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=22&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q2 and first six months fiscal 2024 results, including organic sales, gross margin, segment performance, and liquidity [Executive Summary](index=24&type=section&id=Executive%20Summary) Q2 fiscal 2024 net sales increased to $599.4 million with organic sales up 0.1%, and adjusted diluted EPS rose to $0.88 Q2 Fiscal 2024 Performance vs. Q2 Fiscal 2023 | Metric | Q2 2024 | Q2 2023 | | :--- | :--- | :--- | | Net Sales | $599.4M | $598.4M | | Organic Net Sales Growth | +0.1% | N/A | | GAAP Diluted EPS | $0.72 | $0.37 | | Adjusted Diluted EPS | $0.88 | $0.56 | Six Months Fiscal 2024 Performance vs. Six Months Fiscal 2023 | Metric | Six Months 2024 | Six Months 2023 | | :--- | :--- | :--- | | Net Sales | $1,088.3M | $1,067.5M | | Organic Net Sales Growth | +1.4% | N/A | | GAAP Diluted EPS | $0.81 | $0.61 | | Adjusted Diluted EPS | $1.11 | $0.88 | [Operating and Segment Results](index=26&type=section&id=Operating%20and%20Segment%20Results) Q2 2024 gross margin improved to 43.1%, with varied organic sales performance across Wet Shave, Sun and Skin Care, and Feminine Care segments - Q2 adjusted gross margin increased **320 basis points** to **43.7%**, driven by productivity savings and pricing[109](index=109&type=chunk) - **Wet Shave** organic net sales decreased **4.5%** in Q2, primarily due to a **14.0% decline** in North America[123](index=123&type=chunk) - **Sun and Skin Care** organic net sales grew **11.5%** in Q2, driven by strong growth in global Sun Care and North America Grooming[128](index=128&type=chunk) - **Feminine Care** organic net sales decreased **12.0%** in Q2, mainly due to declines in Tampons and Pads[132](index=132&type=chunk) - A fire at the Wet Ones manufacturing plant resulted in **$3.8 million** of incremental costs in Q2 2024[83](index=83&type=chunk)[138](index=138&type=chunk) [Liquidity and Capital Resources](index=31&type=section&id=Liquidity%20and%20Capital%20Resources) As of March 31, 2024, total borrowings were $1,384.6 million, with $308.7 million available under the revolving credit facility Total Borrowings (in millions) | Category | March 31, 2024 | September 30, 2023 | | :--- | :--- | :--- | | Long-term notes (fixed) | $1,250.0 | $1,250.0 | | Revolver loans (variable) | $111.0 | $122.0 | | Short-term notes payable (variable) | $23.6 | $19.5 | | **Total borrowings** | **$1,384.6** | **$1,391.5** | - As of March 31, 2024, the company had **$308.7 million** available under its **$425.0 million** revolving credit facility[142](index=142&type=chunk) - During the first six months of fiscal 2024, the company repurchased **0.8 million shares** for **$30.3 million**[151](index=151&type=chunk) - On May 8, 2024, the Board declared a quarterly cash dividend of **$0.15 per common share**[152](index=152&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=34&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risks are currency rates, commodity prices, and interest rates, with a 1% rate increase impacting annual expense by $1.4 million - The company's main market risks are from adverse changes in **currency rates**, **commodity prices**, and **interest rates**[158](index=158&type=chunk) - As of March 31, 2024, a hypothetical **1% increase** in interest rates would increase annual interest expense on variable-rate debt by approximately **$1.4 million**[158](index=158&type=chunk) [Controls and Procedures](index=35&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls and procedures were effective as of March 31, 2024, with no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's disclosure controls and procedures were **effective** as of March 31, 2024[162](index=162&type=chunk) - No material changes were made to the internal control over financial reporting during the quarter ended March 31, 2024[163](index=163&type=chunk) [Part II. Other Information](index=36&type=section&id=PART%20II.%20OTHER%20INFORMATION) This section provides details on unregistered equity sales, other information, and a list of exhibits filed with the report [Unregistered Sales of Equity Securities and Use of Proceeds](index=36&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the company's repurchase of 403,118 equity shares in Q2 fiscal 2024, with 3.8 million shares remaining Issuer Purchases of Equity Securities (Q2 2024) | Period | Total Shares Purchased | Average Price Paid per Share | | :--- | :--- | :--- | | January 2024 | 93,248 | $37.00 | | February 2024 | 167,070 | $38.44 | | March 2024 | 142,800 | $37.86 | - During the second quarter of fiscal 2024, the company repurchased a total of **403,118 shares**, with **3,783,617 shares** remaining available for purchase[166](index=166&type=chunk) [Other Information](index=36&type=section&id=Item%205.%20Other%20Information) No director or officer adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter - No director or officer adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter[168](index=168&type=chunk) [Exhibits](index=37&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including governance documents, material contracts, and CEO/CFO certifications - Exhibits filed include **CEO and CFO certifications** (31.1, 31.2, 32.1, 32.2) and various credit and indenture agreements[171](index=171&type=chunk)

For the quarter ended March 2024, Edgewell Personal Care (EPC) reported revenue of $599.4 million, up 0.2% over the same period last year. EPS came in at $0.88, compared to $0.56 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $608.59 million, representing a surprise of -1.51%. The company delivered an EPS surprise of +18.92%, with the consensus EPS estimate being $0.74.While investors scrutinize revenue and earnings changes year-over-year and how they compare with W ...

Financial Performance - Net sales for Q2 2024 were $599.4 million, a 0.2% increase year-over-year, with organic net sales up 0.1%[3] - GAAP EPS rose to $0.72, a 95% increase from $0.37 in the prior year quarter, while adjusted EPS increased to $0.88, up 57% from $0.56[3] - Gross profit was $258.1 million, with a gross margin of 43.1%, reflecting a 260-basis point increase compared to the prior year[5] - Adjusted EBITDA for Q2 2024 was $99.7 million, compared to $83.6 million in the prior year quarter[12] - Operating income increased to $70.1 million for the three months ended March 31, 2024, up from $56.8 million in the prior year, marking a growth of 23.1%[33] - Net earnings for the six months ended March 31, 2024, were $40.8 million, compared to $31.8 million in the same period of 2023, indicating a year-over-year increase of 28.3%[33] - Free cash flow for the six months ended March 31, 2024, was $56.1 million, significantly higher than $1.9 million in the same period of 2023[38] - GAAP reported net earnings for Q2 2024 were $36.0 million, with diluted EPS of $0.72, compared to $19.4 million and $0.37 in Q2 2023, representing a 85.0% increase in net earnings and a 94.6% increase in EPS[43] - Total adjusted non-GAAP net earnings for Q2 2024 were $44.0 million, with diluted EPS of $0.88, compared to $29.4 million and $0.56 in Q2 2023, reflecting a 49.5% increase in net earnings and a 57.1% increase in EPS[43] Segment Performance - The Wet Shave segment reported net sales of $293.1 million for the three months ended March 31, 2024, down from $308.6 million in 2023, a decline of 5.5%[41] - The Sun and Skin Care segment saw an increase in net sales to $235.8 million for the three months ended March 31, 2024, compared to $209.7 million in the same period of 2023, a growth of 12.4%[41] - The Wet Shave segment reported Q2 2024 net sales of $293.1 million, down 5.0% from $308.6 million in Q2 2023, while the Sun and Skin Care segment saw an increase of 12.4% to $235.8 million[50] - The Feminine Care segment experienced a decline in Q2 2024 net sales to $70.5 million, down 12.0% from $80.1 million in Q2 2023[50] - Total segment profit for the three months ended March 31, 2024, was $103.5 million, up from $87.6 million in the same period of 2023, reflecting a growth of 18.2%[41] - Segment profit for Q2 2024 reached $103.5 million, an increase of 18.2% compared to Q2 2023's $87.6 million[52] - Organic growth in the Wet Shave segment was 19.2%, with segment profit increasing from $35.4 million in Q2 2023 to $40.4 million in Q2 2024[52] - The Sun and Skin Care segment saw a profit decrease of 28.7%, with segment profit at $8.7 million in Q2 2024 compared to $12.2 million in Q2 2023[52] Shareholder Returns and Dividends - The company returned $23.5 million to shareholders through share repurchases of $15.3 million and dividends of $8.2 million[3] - The Board declared a cash dividend of $0.15 per common share for Q2 2024, payable on July 9, 2024[15] Future Outlook - Organic net sales growth is now expected to be at the lower end of the 2% to 4% range for the full fiscal year 2024[20] - Adjusted EPS outlook for fiscal 2024 has been raised to a range of $2.80 to $3.00, previously $2.65 to $2.85[20] - The company expects adjusted EBITDA for fiscal 2024 to be in the range of $348 to $360 million, up from the previous range of $340 to $352 million[20] - Capital expenditures are expected to be approximately 2.5% to 3.0% of net sales for fiscal 2024[20] - The company expects fiscal 2024 GAAP EPS to be in the range of $2.20 to $2.40, with adjusted EPS projected at approximately $2.80 to $3.00[56] - Interest expense for the fiscal year is estimated at approximately $75 million, indicating a stable financial outlook[57] Financial Position - The company’s total assets increased to $3,756.3 million as of March 31, 2024, compared to $3,740.7 million as of September 30, 2023[36] - Net debt as of March 31, 2024, was $1,178.2 million, slightly up from $1,163.8 million as of September 30, 2023[55] - The net debt leverage ratio is defined as net debt divided by trailing twelve-month adjusted EBITDA, providing insight into the company's financial leverage[31] Restructuring and Expenses - The company incurred restructuring and repositioning expenses of $10.0 million for the six months ended March 31, 2024, impacting overall profitability[45] - The company incurred restructuring and repositioning expenses of approximately $19 million for fiscal 2024, which will affect adjusted earnings[57] Currency Impact - The impact of currency fluctuations on segment profit was minimal, with a total impact of $(0.7) million for Q2 2024[52]

The upcoming report from Edgewell Personal Care (EPC) is expected to reveal quarterly earnings of $0.74 per share, indicating an increase of 32.1% compared to the year-ago period. Analysts forecast revenues of $608.59 million, representing an increase of 1.7% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reveals its ea ...

Middle and High School Art Teachers Will Be Eligible for the Grand PrizeSHELTON, Conn., April 29, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) and the Dollar General Literacy Foundation (DGLF) announced the second annual Emerging Artist Contest, focused on educators for 2024. Middle and High School art teachers are encouraged to visit EmergingArtistProject.com to enter their original piece of artwork for consideration to win a one-time prize and the chance for their design to be featured ...